On 2 July 2019 the Patented Medicines Prices Review Board (PMPRB) Steering Committee on the Modernisation of Price Review Process Guidelines released its final report summarising its deliberations in providing stakeholder feedback on the PMPRB's proposed new framework for the regulation of the prices of patented medicines. PMPRB officials presented a draft of this report to the steering committee on 13 May 2019 (for further details please see "Update on PMPRB guidelines modernisation"). The PMPRB will publish draft guidelines for public consultation once the board has had an opportunity to review the steering committee's final report and once the amended Patented Medicines Regulations have been published.
This article was first published by the International Law Office, a premium online legal update service for major companies and law firms worldwide. Register for a free subscription.
